| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |